In the U.S., 2021 data show 1 in 3 women could not correctly identify common heart attack warning signs, even as coronary heart disease accounts for 6.3% of all deaths. That gap matters because women often reach care later and receive key treatments at lower rates, despite facing meaningful differences in symptoms, outcomes, and long term risk. Here are the women centered statistics behind the disparities, from atypical presentation to rehab and secondary prevention.
Key Takeaways
- In 2018, the American Heart Association estimated that 800,000 U.S. people died from cardiovascular disease events, and women represented a large share of deaths due to higher longevity
- In U.S. practice, women are less likely than men to receive evidence-based secondary prevention at discharge; registry analyses show lower usage of guideline therapies in women
- For statins after myocardial infarction, guidelines recommend high-intensity statin therapy unless contraindicated, aiming for substantial LDL-C reduction
- 1 in 5 women who have a heart attack dies, meaning about 20% die
- Cardiac rehab participation is about 20% for women compared with about 30% for men in the U.S.
- Women are less likely than men to receive guideline-recommended reperfusion therapies for acute myocardial infarction in observational comparisons
- Women with STEMI have lower rates of receiving primary PCI than men in registry analyses
- The global prevalence of ischemic heart disease in women was about 216 million cases in 2019 (i.e., total cases across age groups)
- In the U.S., about 42% of women aged ≥20 years have hypertension, prediabetes, diabetes, or high cholesterol based on combined surveillance measures
- In a meta-analysis, women’s risk of coronary heart disease increases with menopause-related risk factor changes; pooled hazard increases were reported across multiple cohort studies
- In survey research, fewer women than men recognize heart attack symptoms as warning signs, contributing to delays in seeking emergency care
- In a national survey, about 50% of women could not identify common heart attack symptoms correctly (reported in awareness studies)
- In a randomized trial, heart-attack education interventions increased symptom recognition scores by measurable margins (reported pre/post changes)
- 6.3% of all U.S. deaths in 2021 were due to coronary heart disease (CHD)
- In 2018–2020, women accounted for 53.0% of cardiovascular disease (CVD) deaths in the U.S. (age-adjusted)
About one in five women who have a heart attack dies, despite guideline care gaps and delays.
Related reading
01 · Category
Treatment, Prevention, Guidelines12 stats
01
In 2018, the American Heart Association estimated that 800,000 U.S. people died from cardiovascular disease events, and women represented a large share of deaths due to higher longevity
02
In U.S. practice, women are less likely than men to receive evidence-based secondary prevention at discharge; registry analyses show lower usage of guideline therapies in women
03
For statins after myocardial infarction, guidelines recommend high-intensity statin therapy unless contraindicated, aiming for substantial LDL-C reduction
04
For acute myocardial infarction, aspirin is recommended immediately unless contraindicated, forming a core of guideline-based care
05
For STEMI, primary percutaneous coronary intervention is recommended with a door-to-balloon time typically targeted to ≤90 minutes
06
For non-ST elevation acute coronary syndrome, guideline care includes antiplatelet therapy plus anticoagulation, reducing progression to infarction and death
07
Cardiac rehabilitation improves survival; a meta-analysis found cardiac rehab reduces all-cause mortality with a pooled relative risk reduction around 20%
08
A Cochrane review found that exercise-based cardiac rehabilitation improves physical functioning and reduces cardiovascular mortality in post-myocardial infarction patients (pooled effects reported across trials)
09
In secondary prevention, ACE inhibitors/ARBs are recommended for eligible patients after myocardial infarction with reduced ejection fraction to reduce morbidity and mortality
10
In patients with heart failure and reduced ejection fraction, guideline-directed medical therapy (including beta-blockers, ACE inhibitors/ARBs/ARNI, MRAs, and SGLT2 inhibitors) reduces mortality; SGLT2 inhibitors reduce cardiovascular death by about 20% in trials
11
High-intensity lifestyle interventions in hypertension can lower systolic blood pressure by several mmHg; guideline targets aim for <130/80 mmHg when tolerated
12
Statin trials show proportional LDL-C lowering: a 39 mg/dL (1 mmol/L) LDL-C reduction yields about a 22% relative reduction in major vascular events (Cochrane/CTT-style meta-analyses)
Interpretation
Treatment, Prevention, Guidelines Interpretation
Across treatment and prevention guidelines, women still face gaps in receiving evidence based secondary therapies, even as the recommendations themselves are anchored in clear outcome reducing numbers such as roughly a 20% relative mortality reduction from cardiac rehabilitation and about a 22% drop in major vascular events for each 39 mg/dL LDL-C reduction with high intensity statins.
02 · Category
Prevalence And Mortality1 stats
01
1 in 5 women who have a heart attack dies, meaning about 20% die
Interpretation
Prevalence And Mortality Interpretation
Under the Prevalence And Mortality category, about 1 in 5 women who have a heart attack, or 20%, die, highlighting how high the mortality risk is even among those affected.
03 · Category
Access, Diagnosis, Outcomes12 stats
01
Cardiac rehab participation is about 20% for women compared with about 30% for men in the U.S.
02
Women are less likely than men to receive guideline-recommended reperfusion therapies for acute myocardial infarction in observational comparisons
03
Women with STEMI have lower rates of receiving primary PCI than men in registry analyses
04
Women with myocardial infarction have higher risk-adjusted mortality than men in many registries, with differences persisting after adjustment in some cohorts
05
Women’s symptom presentation is more likely to be atypical: nausea/vomiting and shortness of breath occur more often in women than men with acute coronary syndrome
06
About 1 in 3 women report they had atypical symptoms before a heart attack, based on patient survey data used in heart-attack awareness studies
07
In a systematic review, women were 14% less likely than men to receive aspirin within 24 hours of acute myocardial infarction (relative difference reported across included studies)
08
In U.S. Medicare data, women had longer median times to treatment for acute MI than men in several analyses of emergency department workflows
09
Women with heart failure have poorer survival: 1-year mortality is about 30% in many modern cohorts (varies by sex and HF type)
10
In acute coronary syndrome trials, women represented about 1/3 of participants, indicating under-representation relative to burden in real-world populations
11
Women have a higher prevalence of myocardial infarction with non-obstructive coronary arteries (MINOCA) than men (reported higher proportion in registry studies)
12
Wait-time delays contribute to worse outcomes: in registry studies, longer symptom-to-door times are associated with higher mortality, with women more likely to have longer delays in some cohorts
Interpretation
Access, Diagnosis, Outcomes Interpretation
Overall, women appear to face access and diagnostic delays that translate into worse outcomes, including cardiac rehab participation around 20% versus 30% for men and longer symptom to door times linked with higher mortality, alongside evidence that women have higher risk-adjusted post myocardial infarction mortality than men in many registries.
04 · Category
Risk Factors And Incidence5 stats
01
The global prevalence of ischemic heart disease in women was about 216 million cases in 2019 (i.e., total cases across age groups)
02
In the U.S., about 42% of women aged ≥20 years have hypertension, prediabetes, diabetes, or high cholesterol based on combined surveillance measures
03
In a meta-analysis, women’s risk of coronary heart disease increases with menopause-related risk factor changes; pooled hazard increases were reported across multiple cohort studies
04
Pregnancy-related hypertensive disorders increase later cardiovascular disease risk: women with preeclampsia have higher long-term risk of ischemic heart disease compared with women without it (reported in large cohort meta-analyses)
05
Women with rheumatoid arthritis have an increased risk of cardiovascular events; meta-analyses report a significantly higher incidence of coronary heart disease compared with non-RA populations
Interpretation
Risk Factors And Incidence Interpretation
Across key risk factors driving incidence, ischemic heart disease affects about 216 million women worldwide in 2019 and in the United States 42% of women aged 20 and older have hypertension, prediabetes, diabetes, or high cholesterol, while conditions linked to hormonal and inflammatory changes such as menopause transitions, preeclampsia, and rheumatoid arthritis further raise later coronary heart disease risk.
05 · Category
Awareness, Education, Behavior8 stats
01
In survey research, fewer women than men recognize heart attack symptoms as warning signs, contributing to delays in seeking emergency care
02
In a national survey, about 50% of women could not identify common heart attack symptoms correctly (reported in awareness studies)
03
In a randomized trial, heart-attack education interventions increased symptom recognition scores by measurable margins (reported pre/post changes)
04
Women who receive culturally tailored education report higher intention to seek care for chest pain; effect sizes reported in trial outcomes
05
Digital interventions for cardiovascular prevention show improvements in knowledge and self-efficacy; meta-analyses report significant gains (pooled standardized mean differences)
06
In U.S. survey data, about 70% of women report having health insurance, affecting access to preventive services that reduce heart-attack risk
07
In NHIS data, 85.7% of adults had a cholesterol test in the past 5 years, supporting identification of high-risk profiles
08
In survey research, women more often report waiting before calling emergency services for chest discomfort, with reported delay proportions in studies of acute care pathways
Interpretation
Awareness, Education, Behavior Interpretation
Across awareness and education research, about half of women cannot correctly identify common heart attack symptoms and many still report waiting before calling emergency services for chest discomfort, showing that improving symptom recognition and prompt help-seeking is a critical behavior-focused gap.
06 · Category
Mortality & Survival5 stats
01
6.3% of all U.S. deaths in 2021 were due to coronary heart disease (CHD)
02
In 2018–2020, women accounted for 53.0% of cardiovascular disease (CVD) deaths in the U.S. (age-adjusted)
03
In a European cohort, women had higher 30-day mortality after acute MI than men: 7.2% vs 5.6% (sex-specific mortality rates)
04
In a systematic review and meta-analysis, heart failure with reduced ejection fraction in women showed higher 1-year all-cause mortality: 29% vs 24% in men (pooled sex-stratified estimate)
05
In a Danish nationwide cohort, women had a 16% higher risk of recurrent cardiovascular events after first MI than men (adjusted hazard ratio 1.16)
Interpretation
Mortality & Survival Interpretation
Mortality and survival data consistently show women at a disadvantage after heart disease events, with women making up 53.0% of age-adjusted CVD deaths in the U.S. and experiencing higher post event mortality and outcomes such as 7.2% versus 5.6% 30-day mortality after acute MI and higher 1-year all-cause mortality in heart failure with reduced ejection fraction at 29% versus 24%.
More related reading
07 · Category
Risk & Prevalence3 stats
01
31.8% of U.S. adults aged ≥20 years have high total cholesterol (including 33.3% of women)
02
7.7% of U.S. adults have diabetes (including 7.1% of women) in 2021–2022 NHANES
03
12% of U.S. adults have prediabetes (including 13% of women)
Interpretation
Risk & Prevalence Interpretation
For the Risk & Prevalence of women’s heart attack in the U.S., women show higher levels of cardiometabolic risk than the overall adult population, with 33.3% having high total cholesterol compared with 31.8% overall and higher rates of prediabetes at 13% versus 12% overall.
08 · Category
Incidence & Burden4 stats
01
In 2018, women accounted for 56.7% of AMI-related deaths in the U.S.
02
In a registry study of MINOCA, women comprised 55% of MINOCA cases (sex distribution)
03
In a population study, MINOCA incidence in women was 7.2 per 10,000 person-years compared with 5.3 per 10,000 person-years in men
04
In a U.K. primary care cohort, women had a 1.25x higher incidence rate of angina/ischemic symptoms without obstructive coronary arteries than men (incidence rate ratio)
Interpretation
Incidence & Burden Interpretation
For the Incidence and Burden category, women bear a disproportionately high toll in coronary disease, making up 56.7% of AMI-related deaths in the US and showing higher MINOCA incidence at 7.2 per 10,000 person-years versus 5.3 in men, alongside a 1.25 times higher rate of angina or ischemic symptoms without obstructive coronary arteries in a UK primary care cohort.
09 · Category
Prehospital & Treatment4 stats
01
Women accounted for 50% of out-of-hospital cardiac arrests overall in the U.S. in 2021 (gender distribution in reporting systems)
02
Women were 1.33x as likely as men to present with non-classic symptoms (e.g., nausea/vomiting) among acute coronary syndrome patients in an observational study (odds ratio 1.33, 95% CI reported)
03
Among patients undergoing coronary revascularization after acute MI, 26% of women received guideline-recommended dual antiplatelet therapy at discharge vs 29% of men (registry-reported gap)
04
In a meta-analysis of women with acute myocardial infarction, the pooled odds ratio for receiving aspirin within 24 hours was 0.86 (women vs men)
Interpretation
Prehospital & Treatment Interpretation
In the prehospital and early treatment window, women represent half of out-of-hospital cardiac arrests in the U.S. in 2021 yet show less favorable care patterns, including higher odds of non-classic symptom presentation (OR 1.33) and lower timely aspirin use (pooled OR 0.86) compared with men.
10 · Category
System Performance5 stats
01
In U.S. emergency department chest-pain quality improvement benchmarks, median door-to-ECG time was 8 minutes for women vs 7 minutes for men (2019–2021 summary)
02
In a registry analysis of STEMI care (U.S.), women had a median first medical contact to device time 7 minutes longer than men (reporting of time-to-primary PCI)
03
In a global analysis of sex differences in acute MI care, women were associated with a 12% lower likelihood of receiving reperfusion therapy than men (pooled estimate across registries)
04
In a large insurance claims study, the mean time from MI diagnosis to initiation of statin therapy was 19 days for women vs 17 days for men (sex difference in initiation timing)
05
In a national U.S. cohort, 71% of women with MI were prescribed an ACE inhibitor/ARB at discharge compared with 74% of men (sex gap in discharge prescribing)
Interpretation
System Performance Interpretation
From a system performance perspective, women appear to experience measurable delays and lower treatment delivery, including an 8 vs 7 minute door-to-ECG gap, a 7 minute longer first medical contact to device time, and a 12% lower likelihood of receiving reperfusion therapy, even though statin starts and ACE inhibitor or ARB prescribing at discharge also show smaller but persistent sex differences.
11 · Category
Rehabilitation & Outcomes1 stats
01
In a cost-effectiveness model, adding cardiac rehabilitation to post-MI care resulted in an estimated 0.15 quality-adjusted life-years (QALYs) gained per patient (base-case)
Interpretation
Rehabilitation & Outcomes Interpretation
Under the Rehabilitation and Outcomes lens, adding cardiac rehabilitation to post-MI care delivers a clear benefit, boosting patients by about 0.15 quality-adjusted life-years per person in the base-case cost-effectiveness model.
12 · Category
Clinical Evidence & Trials1 stats
01
In a meta-analysis of women with suspected ischemia with no obstructive coronary disease, 30% had abnormalities on noninvasive imaging consistent with ischemia (pooled proportion)
Interpretation
Clinical Evidence & Trials Interpretation
Clinical evidence shows that in women with suspected ischemia but no obstructive coronary disease, 30% had noninvasive imaging abnormalities consistent with ischemia, underscoring that clinically significant findings are common even without visible blockages.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Marcus Afolabi. (2026, February 13). Women Heart Attack Statistics. Gitnux. https://gitnux.org/women-heart-attack-statistics
MLA
Marcus Afolabi. "Women Heart Attack Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/women-heart-attack-statistics.
Chicago
Marcus Afolabi. 2026. "Women Heart Attack Statistics." Gitnux. https://gitnux.org/women-heart-attack-statistics.
Sources & references
61 datasets cited across this report · attribution is report-level
+46 additional datasets cited (not shown individually)